These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 26031448)

  • 1. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
    Xu B; Peng F; Tang W; Du Y; Guo H
    Ann Pharmacother; 2016 Sep; 50(9):697-705. PubMed ID: 27317015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH; Warraich M; Whitfield MG; Peter CU; Baral R; Ahmad M; Ahmad S; Abraham GR; Kirresh A; Sahibzada MS; Muzaffar A; Tomson J; Lambiase PD; Captur G; Banerjee A; Providencia R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013765. PubMed ID: 36915032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
    Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G
    Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
    Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
    BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
    Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
    JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy.
    Yi F; Hou W; Zhou C; Yin Y; Lu S; Duan C; Cao M; Li M; Toft ES; Zhang H
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):241-247. PubMed ID: 30688797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis.
    Khan AR; Khan S; Sheikh MA; Khuder S; Grubb B; Moukarbel GV
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):853-60. PubMed ID: 25110162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
    Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
    Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of medical management versus catheter ablation for atrial fibrillation.
    Mao YJ; Wang H; Chen JX; Huang PF
    Rev Cardiovasc Med; 2020 Sep; 21(3):419-432. PubMed ID: 33070546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
    Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA
    J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
    Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
    Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
    Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
    Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
    Ad N; Holmes SD; Shuman DJ; Pritchard G; Miller CE
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):798-803. PubMed ID: 26253874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up.
    Lodziński P; Kiliszek M; Koźluk E; Piątkowska A; Balsam P; Kochanowski J; Scisło P; Piątkowski R; Opolski G
    Cardiol J; 2014; 21(4):384-91. PubMed ID: 24142681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to recurrence of atrial fibrillation influences outcome following catheter ablation.
    Gaztañaga L; Frankel DS; Kohari M; Kondapalli L; Zado ES; Marchlinski FE
    Heart Rhythm; 2013 Jan; 10(1):2-9. PubMed ID: 22982966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.
    Anselmino M; Matta M; D'ascenzo F; Pappone C; Santinelli V; Bunch TJ; Neumann T; Schilling RJ; Hunter RJ; Noelker G; Fiala M; Frontera A; Thomas G; Katritsis D; Jais P; Weerasooriya R; Kalman JM; Gaita F
    Europace; 2015 Oct; 17(10):1518-25. PubMed ID: 26498716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
    Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.